Table 1.
Overview on the global prevalence of endophthalmitis
| Study | Country | Incidence of endophthalmitis (%) |
|---|---|---|
| Africa | 26/8190 (0.32%) | |
| van der Merwe et al. (2012) | South Africa | 26/8190 (0.32%) |
| Asia | 1108/763 690 (0.15%) | |
| Lin et al. (2011) | China | 9/94 650 (0.01%) |
| Yao et al. (2013) | China | 66/201 757 (0.03%) |
| Lalitha et al. (2005) | India | 19/22 294 (0.09%) |
| Ravindran et al. (2009) | India | 38/42 426 (0.09%) |
| Haripriya et al. (2012) | India | 21/79 777 (0.03%) |
| Matsuura et al. (2013) | Japan | 11/34 762 (0.03%) |
| Nagaki et al. (2003) | Japan | 15/11 595 (0.13%) |
| Al‐Mezaine et al. (2009) | Saudi Arabia | 20/29 509 (0.07%) |
| Wong & Chee (2004b) | Singapore | 34/44 803 (0.08%) |
| Tan et al. (2012) | Singapore | 21/50 177 (0.04%) |
| Wu et al. (2006a) | Taiwan | 46/21 562 (0.21%) |
| Wu et al. (2006b) | Taiwan | 12/10 614 (0.11%) |
| Fang et al. (2006) | Taiwan | 772/108 705 (0.71%) |
| Trinavarat et al. (2006) | Thailand | 24/11 059 (0.22%) |
| Australia | 723/504 471 (0.14%) | |
| Ellis (2003) | Australia | 5/633 (0.79%) |
| Semmens et al. (2003) | Australia | 188/94 653 (0.20%) |
| Li et al. (2004) | Australia | 210/117 083 (0.18%) |
| Rosha et al. (2006) | Australia | 92/162 120 (0.06%) |
| Clark et al. (2011) | Australia | 228/129 982 (0.18%) |
| Europe | 1253/1 777 045 (0.07%) | |
| ESCRS 2007 (ESCRS Endophthalmitis Study Group 2007) | Europe | 29/16 603 (0.17%) |
| Eurequo 2012 (Lundstrom et al. 2012) | Europe | 148/406 703 (0.04%) |
| Haapala et al. (2005) | Finland | 47/29 350 (0.16%) |
| Barreau et al. (2012) | France | 36/5115 (0.70%) |
| Ness et al. (2011) | Germany | 16/26 566 (0.06%) |
| Krikonis et al. (2009) | Greece | 7/8393 (0.08%) |
| Khan et al. (2005) | Ireland | 43/8763 (0.49%) |
| Rahman & Murphy (2014) | Ireland | 5/8239 (0.06%) |
| Kessner et al. (2014) | Israel | 40/13 284 (0.30%) |
| Råen et al. (2013) | Norway | 9/15 954 (0.06%) |
| Beselga et al. (2014) | Portugal | 16/15 689 (0.10%) |
| Garat et al. (2005) | Spain | 31/18 579 (0.17%) |
| Garcia‐Saenz et al. (2010) | Spain | 42/13 652 (0.31%) |
| Romero‐Aroca et al. (2012) | Spain | 83/25 001 (0.33%) |
| Rodriguez‐Caravaca et al. (2013) | Spain | 44/19 463 (0.23%) |
| Montan et al. (2002a) | Sweden | 20/32 180 (0.06%) |
| Wejde et al. (2005a) | Sweden | 112/188 151 (0.06%) |
| Lundstrom et al. (2007) | Sweden | 109/225 471 (0.05%) |
| Friling et al. (2013) | Sweden | 135/464 996 (0.03%) |
| Mayer et al. (2003) | UK | 30/18 191 (0.16%) |
| Patwardhan et al. (2006) | UK | 44/12 362 (0.36%) |
| Kelly et al. (2007) | UK | 7/12 831 (0.05%) |
| Mollan et al. (2007) | UK | 101/101 920 (0.10%) |
| Yu‐Wai‐Man et al. (2008) | UK | 46/38 819 (0.12%) |
| Carrim et al. (2009) | UK | 25/12 500 (0.20%) |
| Anijeet et al. (2010) | UK | 14/16 606 (0.08%) |
| Myneni et al. (2013) | UK | 14/21 664 (0.06%) |
| North America | 6935/5 122 623 (0.14%) | |
| Shorstein et al. (2013) | California | 19/16 264 (0.12%) |
| Lloyd & Braga‐Mele (2009) | Canada | 6/13 931 (0.04%) |
| Hatch et al. (2009) | Canada | 617/422 177 (0.15%) |
| Freeman et al. (2010) | Canada | 754/490 690 (0.15%) |
| Rudnisky et al. (2014) | Canada | 23/75 318 (0.03%) |
| Miller et al. (2005) | Florida | 7/15 920 (0.04%) |
| Wykoff et al. (2010) | Florida | 8/28 568 (0.03%) |
| Thoms et al. (2007) | Michigan | 5/815 (0.61%) |
| Buzard & Liapis (2004) | Nevada | 0/5131 (0%) |
| Wallin et al. (2005) | Utah | 27/15 254 (0.18%) |
| Jensen et al. (2005) | Utah | 26/9079 (0.29%) |
| Moshirfar et al. (2007) | Utah | 14/20 013 (0.07%) |
| Jensen et al. (2008) | Utah | 40/29 276 (0.14%) |
| West et al. (2005) | USA | 1026/477 627 (0.21%) |
| Stein et al. (2011) | USA | 357/221 594 (0.16%) |
| Keay et al. (2012) | USA | 4006/3 280 966 (0.12%) |
| South America | 74/27 264 (0.27%) | |
| Melo et al. (2010) | Brazil | 73/24 590 (0.30%) |
| Galvis et al. (2014) | Colombia | 1/2674 (0.04%) |